Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes
Katherine V. Towns(St James's University Hospital), Chris F. Inglehearn(University of Leeds), James O’Sullivan(NIHR Manchester Biomedical Research Centre), Graeme C. Black(University of Manchester), Parastoo Ehsani(Pasteur Institute of Iran), David A. Mackey(Lions Eye Institute), Eric A. Pierce(Broad Institute), Athina Kipioti(St James's University Hospital), Raj Ramesar, Jean D. Beggs(Wellcome Centre for Cell Biology), Veronika Vaclavik(Hôpital Ophtalmique Jules-Gonin), Andrew R. Webster(Moorfields Eye Hospital), Shomi S. Bhattacharya(Centro Andaluz de Biología Molecular y Medicina Regenerativa), Mohammed Kamal(St James's University Hospital), Anthony T. Moore(Cambridge University Hospitals NHS Foundation Trust), Rajarshi Mukhopadhyay(University College London), Vernon Long(St James's University Hospital), Kelly Springell(St James's University Hospital), C. Maubaret(UCL Australia), Martin McKibbin(Leeds Teaching Hospitals NHS Trust)
Cited by 40
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
|Nature Genetics|2015|1.6k
Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies
|International Journal of Epidemiology|2019|1.4k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k